FDA Approved: DEFERASIROX — Original Application (Amneal Pharmaceuticals NY LLC)

View source ↗

Summary

The FDA approved Amneal's generic deferasirox (Deferasirox) as an original ANDA for the treatment of transfusion-related iron overload in patients with chronic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia
• Beta Thalassemia Major
• Myelodysplastic Syndromes
• Sickle Cell Disease
• Transfusion-dependent Iron Overload

Drugs mentioned

• Deferasirox (Deferasirox)

Snippet

ORIG AP for DEFERASIROX (DEFERASIROX)